Zródło

Literatura:
Bures J., Cyrany J. i in.,
Small intestinal bacterial overgrowth syndrome.
World J Gastroenterol. 2010 Jun 28;16(24):2978–90,
Compare D., Pica L. i in.,
Effects of long-term PPI treatment on producing bowel symptoms and SIBO.
Eur J Clin Invest. 2011 Apr;41(4):380–6,
Greco A., Caviglia G. P. i in.,
Glucose breath test and Crohn’s disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response.
Scand J Gastroenterol. 2015;50(11):1376–81,
Ghoshal U.C., Srivastava D.,
Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.
World J Gastroenterol. 2014 Mar 14;20(10):2482–91,
Ponziani F. R., Gerardi V., Gasbarrini A.,
Diagnosis and treatment of small intestinal bacterial overgrowth.
Expert Rev Gastroenterol Hepatol. 2016;10(2):215–27,
Chedid V., Dhalla S. i in.,
Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.
Glob Adv Health Med. 2014 May;3(3):16–24,
Rezaie A., Pimentel M., Rao S.S.,
How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.
Curr Gastroenterol Rep. 2016 Feb;18(2):8.